18 reports

China’s demand for Respiratory Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Respiratory Treatment
  • China
  • Industrial Production
  • Labour Force

Forecasts by Product (Formulations, Devices), by Type (Dry Powder, Suspension Aerosol, Solution Aerosol), by Product Type (Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIs), Nebulizers, Accessories), by Nebulizers Type (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), by Canister Type (Plain Canisters, Coated Canister),...

  • Respiratory Treatment
  • World
  • APAC

Pulmonary/ Respiratory Drug Delivery market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pulmonary/ Respiratory Drug Delivery Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pulmonary/ Respiratory Drug...

  • Respiratory Treatment
  • World

The Global Inhaled Nitric Oxide Market size is expected to reach $915.7 Million by 2026, rising at a market growth of 7% CAGR during the forecast period. Nitric oxide is a molecule of gas that causes a sense of relaxation in smooth muscle cells in the vasculature. It is because Nitric Oxide reacts with oxyhemoglobin. The gas is quickly collected...

  • Respiratory Disease
  • Respiratory Treatment
  • World
  • APAC
  • North America
  • Europe
  • Health Provider Density
  • Medical Technology Density

Abstract: - Global Pulmonary/ Respiratory Drug Delivery Market to Reach $59.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pulmonary/ Respiratory Drug Delivery estimated at US$42.3 Billion in the year 2020, is projected to reach a revised size of US$59.8 Billion by 2027, growing at a CAGR of 5.1%...

  • Respiratory Treatment
  • Respiratory Device
  • World
  • China
  • United States

Global Respiratory Drugs Market 2022-2026 The analyst has been monitoring the respiratory drugs market and it is poised to grow by $ 26.95 bn during 2022-2026 progressing at a CAGR of 5.96% during the forecast period. Our report on the respiratory drugs market provides a holistic analysis, market size and forecast, trends,...

  • Respiratory Treatment
  • World

Pulmonary/Respiratory Drug Delivery Market Report 2020-2030: Forecasts by Product (Formulation, Devices), Formulation (Suspension Aerosol, Solution Aerosol, Dry Powder Formulation), Devices (MDIs, DPIs, Nebulizers, Accessories), Nebulizers (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), Canister Type (Plain Canisters,...

  • Respiratory Treatment
  • World

This study focuses on China’s Respiratory Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is...

  • Respiratory Treatment
  • China
  • Employment Costs
  • Pharmaceutical Production

This study focuses on China’s Respiratory Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Respiratory Treatment
  • China
  • Industrial Production
  • Labour Force

This study focuses on China’s Pediatric Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major...

  • Anti-Infective
  • Respiratory Treatment
  • Gastrointestinal Drug
  • Prescription Drug
  • China
  • Industrial Production
  • Labour Force

The North America Inhaled Nitric Oxide Market would witness market growth of 6.1% CAGR during the forecast period (2020-2026). This nitric oxide can be inhaled via the nose or mouth, which helps in relaxing the smooth muscles to broaden all the blood vessels in the oxygenated regions of the lungs. It is mostly utilized together with...

  • Respiratory Disease
  • Respiratory Treatment
  • North America
  • Health Provider Density
  • Medical Technology Density

The Europe Inhaled Nitric Oxide Market would witness market growth of 7.4% CAGR during the forecast period (2020-2026). Nitric oxide is a gas form of the chemical molecule, which is utilized to cure newborn babies with serious breathing problems related to narrow blood vessels in the lungs. It helps in relaxing the muscle while broadening...

  • Respiratory Disease
  • Respiratory Treatment
  • Europe
  • Health Provider Density
  • Medical Technology Density

The Latin America, Middle East and Africa Inhaled Nitric Oxide Market would witness market growth of 8.5% CAGR during the forecast period (2020-2026). Inhaled Nitric Oxide acts as a pulmonary vasodilator that helps in controlling vascular muscle tone. The field of Nitric Oxide has evolved during the last century, to embed various fields...

  • Respiratory Disease
  • Respiratory Treatment
  • World
  • Argentina
  • Brazil
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Health Provider Density
  • Medical Technology Density

The Asia Pacific Inhaled Nitric Oxide Market would witness market growth of 8.9% CAGR during the forecast period (2020-2026). Inhaled Nitric Oxide is basically a vasodilator that makes precisely selective pulmonary vasodilation. Large number of lab and clinical research studies have been conducted to describe the physiology, biochemistry,...

  • Respiratory Disease
  • Respiratory Treatment
  • APAC
  • Health Provider Density
  • Medical Technology Density

Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral®, Coldrex®...

  • Respiratory Treatment
  • World
  • Air Quality Index
  • Asthma Prevalence

About Human Respiratory Syncytial Virus Drugs Respiratory syncytial virus (RSV) is a virus that leads to infections in the lungs and the respiratory tract. It commonly affects most children in the ages 2 or below. RSV can also infect adults. In adults and the older population, the symptoms of RSV are mild and similar to that of common...

  • Therapy
  • Respiratory Treatment
  • Pharmaceutical
  • Clinical Trial
  • Health Services
  • Marketing Research
  • United States
  • World
  • Drug Approval
  • Elderly Population

About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized...

  • Respiratory Treatment
  • Therapy
  • Pharmaceutical
  • China
  • World
  • Smoking Prevalence
  • Health Expenditure

About Respiratory Ailments Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases....

  • Respiratory Treatment
  • Respiratory Disease
  • World
  • Drug Approval
  • Chronic Obstructive Pulmonary Disease Prevalence